http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#Head
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#assertion
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#provenance
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#pubinfo
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#assertion
http://purl.obolibrary.org/obo/DOID_13550
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_13550
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01062
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association
http://www.w3.org/2000/01/rdf-schema#label
"Oxybutynin chloride is contraindicated in patients with untreated angle closure glaucoma and in patients with untreated narrow anterior chamber angles since anticholinergic drugs may aggravate these conditions. It is also contraindicated in partial or complete obstruction of the gastrointestinal tract, paralytic ileus, intestinal atony of the elderly or debilitated patient, megacolon, toxic megacolon complicating ulcerative colitis, severe colitis, and myasthenia gravis. It is contraindicated in patients with obstructive uropathy and in patients with unstable cardiovascular status in acute hemorrhage. Oxybutynin chloride is contraindicated in patients who have demonstrated hypersensitivity to the product."
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB01062
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#provenance
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#pubinfo
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig
http://purl.org/nanopub/x/hasSignature
gpm2zGnIO8q1dO0nVjSJjfF9taZtt48742X+5ebej+ZCi5+mIFDS5oxvgtJ2+BEwejJB20rel5TwWkt9njsCff11JeEfvNfrCVDqErMRL/p631qRcfpiack9tIGTAqXeqfec1DyeOtqOENEPDh9BCfx5wA2mfhRlSl/0eAQvD8A=
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
http://purl.org/dc/terms/created
2021-08-25T13:47:02.040+02:00
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY